Hutson Nancy J bought BCRX

June 12, 2024 · Form 4 insider transaction

Hutson Nancy J bought 49,933 shares of BioCryst Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

49,933

Price

$0.00

Total value

N/A

InsiderHutson Nancy J

Role—

CompanyBioCryst Pharmaceuticals, Inc. (BCRX)

SecurityAutomatic Stock Option Grant

Transaction codeA — Grant or award

Transaction dateJune 12, 2024

Filing dateJune 14, 2024

Shares owned after49,933

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

View the original Form 4 on SEC EDGAR